Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

CD62L (L-selectin) is Not a Reliable Biomarker for Predicting Risk of Progressive Multifocal Leukoencephalopathy in Natalizumab-Treated Multiple Sclerosis Patients
Multiple Sclerosis
(-)
039
Authors/Disclosures
Linda Lieberman
PRESENTER 		No disclosure on file
No disclosure on file
Tatiana Plavina, PhD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Leonid Gorelik, PhD No disclosure on file
Ludwig Kappos, MD, FÂ鶹´«Ã½Ó³»­ (RC2NB, University Hospital Basel) Dr. Kappos has nothing to disclose.
No disclosure on file